Management of hormonal therapy for the treatment of advanced hormone-dependent prostate cancer: A pharmacoeconomics assessment of the use of Degarelix – Firmagon® compared to generic triptorelin. (2024). ACTA MEDICA PERUANA, 28(4), 188-193. https://amp.cmp.org.pe/index.php/AMP/article/view/1118